| Fiscal Period | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Period End Date | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
| Issuance( Retirement)of Debt Net | 2,319.60 | 434.60 | -2,039.70 | 273.50 |
| Net Changein Cash | 748.60 | 132.80 | -907.30 | 3.20 |
| Cash Taxes Paid | 1,999.30 | 2,004.70 | 1,071.40 | 743.70 |
| Net Income/ Starting Line | 7,679.50 | 7,201.00 | 6,048.50 | 3,061.40 |
| Total Cash Dividends Paid | -666.20 | -664.80 | -497.90 | -414.60 |
| Changesin Working Capital | -4,998.20 | -4,022.90 | -1,856.90 | -2,126.00 |
| Cashfrom Operating Activities | 4,642.80 | 4,543.30 | 5,887.50 | 2,810.80 |
| Cash Interest Paid | 348.30 | 226.60 | 185.30 | 134.50 |
| Cashfrom Financing Activities | 1,891.10 | -376.30 | -2,686.10 | -242.20 |
| Issuance( Retirement)of Stock Net | -119.60 | 80.50 | 36.80 | 33.40 |
| Depreciation/ Depletion | 1,703.70 | 1,470.00 | 1,250.20 | 1,165.20 |
| Other Investing Cash Flow Items Total | -2,367.90 | -1,284.80 | -2,250.70 | -733.80 |
| Capital Expenditures | -3,439.80 | -2,743.50 | -1,886.60 | -1,904.90 |
| period Type | - | - | - | - |
| Foreign Exchange Effects | 22.40 | -5.90 | 28.60 | 73.30 |
| Non- Cash Items | 257.80 | -104.80 | 445.70 | 710.20 |
| Financing Cash Flow Items | 357.30 | -226.60 | -185.30 | -134.50 |
| period Length | 12.00 | 12.00 | 12.00 | 12.00 |
| Cashfrom Investing Activities | -5,807.70 | -4,028.30 | -4,137.30 | -2,638.70 |
Dr Reddy's Laboratories Dividend Dr Reddy's Laboratories Bonus Dr Reddy's Laboratories News Dr Reddy's Laboratories AGM Dr Reddy's Laboratories Rights Dr Reddy's Laboratories Splits Dr Reddy's Laboratories Board Meetings Dr Reddy's Laboratories Key Metrics Dr Reddy's Laboratories Shareholdings Dr Reddy's Laboratories Profit Loss Dr Reddy's Laboratories Balance Sheet Dr Reddy's Laboratories Q1 Results Dr Reddy's Laboratories Q2 Results Dr Reddy's Laboratories Q3 Results Dr Reddy's Laboratories Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks